title: Estradiol treatment, physical activity, and muscle function in ovarian-senescent mice.
abstract: Estradiol (E(2)) treatment in young adult, ovariectomized mice increases physical activity and reverses deleterious effects on skeletal muscle. Here we test the hypothesis that E(2) treatment improves muscle function and physical activity in aged, ovarian-senescent mice. Plasma E(2) levels and vaginal cytology confirmed ovarian senescence in 20-month-old C57BL/6 mice. Mice were then randomly divided into activity groups, having access to a running wheel or not, and further into those receiving E(2) or placebo. Placebo-treated mice wheel ran more than E(2)-treated mice (P=0.03), with no difference between treatment groups in cage activities such as time spent being active and ambulation distance (P≥0.55). Soleus muscles from aged mice that wheel ran adapted by getting larger and stronger, irrespective of E(2) status (P≤0.02). Soleus muscle fatigue resistance was greater in mice treated with E(2) (P=0.02), but maximal isometric tetanic force was not affected (P≥0.79). Because E(2) treatment did not improve physical activity or overall muscle function in the aged, ovarian-senescent mice as predicted, a second study was initiated to examine E(2) treatment of young adult mice prematurely ovarian senescent from exposure to the chemical, 4-vinylcyclohexene diepoxide (VCD). Four-month-old C57BL/6 female mice were dosed with oil (control) or VCD. Vaginal cytology confirmed ovarian senescence in all mice treated with VCD 63 days after the onset of dosing, and then a subset of the VCD mice received E(2) (VCD+E(2)). Wheel running distance did not differ among control, VCD, and VCD+E(2) mice (P≥0.34). Soleus muscle concentric, isometric, and eccentric in vitro forces were greater in VCD+E(2) than in VCD mice (P<0.04), indicating beneficial estrogenic effects on muscle function. In general, aged and young mice with senescent ovaries were less responsive to E(2) treatment, in terms of physical activities and muscle function, than what has previously been shown for young, ovariectomized mice. These results bring forth the possibility that some component of the residual, follicle-depleted ovarian tissue influences physical activity in mice or that aging diminishes the responsiveness of skeletal muscle and related tissues to E(2) treatment.
authors.affiliation: Program in Physical Therapy and Rehabilitation Sciences, University of Minnesota, School of Medicine, Minneapolis, MN 55455, USA.
authors.forename: Sarah M
authors.initials: SM
authors.lastname: Greising
authors.forename: Ryan S
authors.initials: RS
authors.lastname: Carey
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Blackford
authors.forename: Laurin E
authors.initials: LE
authors.lastname: Dalton
authors.forename: Allison M
authors.initials: AM
authors.lastname: Kosir
authors.forename: Dawn A
authors.initials: DA
authors.lastname: Lowe
mesh_terms: D000375:Aging / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D053138:Cyclohexenes; D004958:Estradiol / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D051379:Mice; D008810:Mice, Inbred C57BL; D018763:Muscle Fatigue; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D010052:Ovariectomy; D010805:Physical Conditioning, Animal; D011897:Random Allocation; D014753:Vinyl Compounds
chemical_list: D053138:Cyclohexenes; D014753:Vinyl Compounds; D004958:Estradiol; C012606:4-vinyl-1-cyclohexene dioxide